InvestorsHub Logo
Followers 80
Posts 24706
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Wednesday, 03/03/2021 8:10:32 AM

Wednesday, March 03, 2021 8:10:32 AM

Post# of 27624
HOTH - 2.24 Pre-market at 2.30/2.32

Hoth Therapeutics Offers Update On Its Novel Peptide COVID-19 Therapeutic HT-002 Preclinical Studies: 1 Of 3 Peptide Candidates Has Demonstrated Low Level Viral Inhibition Assay With No Toxicity

https://stockcharts.com/h-sc/ui?s=hoth
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.